Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
The importance of IL-33 in allergic inflammation.
Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism.
Supernumerary phantom limbs in ICU patients with acute inflammatory demyelinating polyneuropathy.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
Ultra-high-field MR imaging in multiple sclerosis.
Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Venous endothelial injury in central nervous system diseases.
GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Tremor in neuropathies of different origin.
Enriched CD161high CCR6+ γδ T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Glucocorticoid treatment of multiple sclerosis.
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls.
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.
Sphingosine-1 phosphate and central nervous system.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Bedside tested ocular motor disorders in multiple sclerosis patients.
Pages
« first
‹ previous
…
523
524
525
526
527
528
529
530
531
…
next ›
last »